Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease

Clinical Gastroenterology and Hepatology - United Kingdom
doi 10.1016/j.cgh.2017.08.027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pro-Resolving Lipid Mediators in Vascular Disease

Journal of Clinical Investigation
Medicine
2018English

Albumin: Indications in Chronic Liver Disease

United European Gastroenterology Journal
OncologyGastroenterology
2020English

Effects of Quzhi Sanwei Fang on Liver Function and Serum Lipid in Mice With Nonalcoholic Fatty Liver Disease

Traditional Chinese Medicine
2017English

Disease Targeted Measures of Health Related Quality of Life (HRQOL) in Patients With Advanced Liver Disease Before and After Liver Transplantation

2012English

Ischemia-Modifi Ed Albumin Levels in Children With Chronic Liver Disease

Gut and Liver
HepatologyGastroenterology
2012English

Lipid Mediators in Inflammation

2017English

Correlation Between Serum Ascites Albumin Gradient and Esophageal Varices in Patients of Chronic Liver Disease

Journal of Medical Science And clinical Research
2016English

Risk of Nonsteroidal Anti-Inflammatory Drugs and Safety of Acetaminophen in Patients With Advanced Liver Disease

Clinical Liver Disease
Hepatology
2018English

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

Gastroenterology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy